{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T12:29:22Z","timestamp":1707654562682},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,2]]},"DOI":"10.7759\/cureus.53470","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:01:25Z","timestamp":1706918485000},"source":"Crossref","is-referenced-by-count":0,"title":["Quality Assurance for Stereotactic Body Radiation Therapy for Gynecologic Malignancies"],"prefix":"10.7759","author":[{"given":"Samuel N","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D","family":"Bonnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shraddha M","family":"Dalwadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Koh WJ","year":"2018","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, et al.. Uterine neoplasms, version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018, 16:170-99. 10.6004\/jnccn.2018.0006","journal-title":"J Natl Compr Canc Netw"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical cancer, version 3.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Koh WJ","year":"2019","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, et al.. Cervical cancer, version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019, 17:64-84. 10.6004\/jnccn.2019.0001","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2023.09.008","article-title":"Stereotactic body radiation therapy for gynecologic malignancies: a case-based Radiosurgery Society practice review","author":"Ladbury C","year":"2023","unstructured":"Ladbury C, Sueyoshi MH, Brovold NM, et al.. Stereotactic body radiation therapy for gynecologic malignancies: a case-based Radiosurgery Society practice review. Pract Radiat Oncol. 2023, 10.1016\/j.prro.2023.09.008","journal-title":"Pract Radiat Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters L","year":"2010","unstructured":"Potters L, Kavanagh B, Galvin JM, et al.. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010, 76:326-32. 10.1016\/j.ijrobp.2009.09.042","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001200","article-title":"Stereotactic body radiation therapy, intensity-modulated radiation therapy, and brachytherapy boost modalities in invasive cervical cancer: a study of the National Cancer Data Base","volume":"28","author":"O\u02bcDonnell B","year":"2018","unstructured":"O\u02bcDonnell B, Shiao JC, Pezzi TA, Waheed N, Sharma S, Bonnen MD, Ludwig MS. Stereotactic body radiation therapy, intensity-modulated radiation therapy, and brachytherapy boost modalities in invasive cervical cancer: a study of the National Cancer Data Base. Int J Gynecol Cancer. 2018, 28:563-74. 10.1097\/IGC.0000000000001200","journal-title":"Int J Gynecol Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-001104","article-title":"Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer","volume":"30","author":"Dalwadi S","year":"2020","unstructured":"Dalwadi S, Echeverria A, Jhaveri P, et al.. Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2020, 30:1684-8. 10.1136\/ijgc-2019-001104","journal-title":"Int J Gynecol Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13566-019-00403-0","article-title":"Definitive chemoradiation followed by stereotactic body radiotherapy boost for inoperable endometrial cancer.","volume":"8","author":"Dalwadi S","year":"2019","unstructured":"Dalwadi S, Mantz C, Tung B, Waheed N, Tran D, Bonnen M, Ludwig M. Definitive chemoradiation followed by stereotactic body radiotherapy boost for inoperable endometrial cancer.. J Radiat Oncol. 2019, 8:329-35. 10.1007\/s13566-019-00403-0","journal-title":"J Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2018.01.001","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter R","year":"2018","unstructured":"P\u00f6tter R, Tanderup K, Kirisits C, et al.. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018, 9:48-60. 10.1016\/j.ctro.2018.01.001","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(99)00330-2","article-title":"A simple method of obtaining equivalent doses for use in HDR brachytherapy","volume":"46","author":"Nag S","year":"2000","unstructured":"Nag S, Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2000, 46:507-13. 10.1016\/s0360-3016(99)00330-2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak A","year":"2019","unstructured":"Bezjak A, Paulus R, Gaspar LE, et al.. Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 trial. J Clin Oncol. 2019, 37:1316-25. 10.1200\/JCO.18.00622","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.08.030","article-title":"Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials","volume":"109","author":"King CR","year":"2013","unstructured":"King CR, Freeman D, Kaplan I, et al.. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol. 2013, 109:217-21. 10.1016\/j.radonc.2013.08.030","journal-title":"Radiother Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2011.12.001","article-title":"Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer","volume":"11","author":"Cengiz M","year":"2012","unstructured":"Cengiz M, Dogan A, Ozyigit G, et al.. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy. 2012, 11:125-9. 10.1016\/j.brachy.2011.12.001","journal-title":"Brachytherapy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.brachy.2016.10.004","article-title":"Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy","volume":"16","author":"Kauffmann G","year":"2017","unstructured":"Kauffmann G, Wu T, Al-Hallaq H, Hasan Y. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy. Brachytherapy. 2017, 16:141-6. 10.1016\/j.brachy.2016.10.004","journal-title":"Brachytherapy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.1343","article-title":"Stereotactic body radiation therapy as a boost alternative for nonmetastatic cancer of the cervix and endometrium: disease control and quality of life outcomes from a phase 2 trial at 3 years\u2019 minimum follow-up.","volume":"96","author":"Mantz CA","year":"2016","unstructured":"Mantz CA. Stereotactic body radiation therapy as a boost alternative for nonmetastatic cancer of the cervix and endometrium: disease control and quality of life outcomes from a phase 2 trial at 3 years\u2019 minimum follow-up.. Int J Radiat Oncol Biol Phys. 2016, 96:286. 10.1016\/j.ijrobp.2016.06.1343","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.10.042","article-title":"A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer","volume":"106","author":"Albuquerque K","year":"2020","unstructured":"Albuquerque K, Tumati V, Lea J, Ahn C, Richardson D, Miller D, Timmerman R. A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2020, 106:464-71. 10.1016\/j.ijrobp.2019.10.042","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/196859-quality-assurance-for-stereotactic-body-radiation-therapy-for-gynecologic-malignancies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:17:41Z","timestamp":1707509861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/196859-quality-assurance-for-stereotactic-body-radiation-therapy-for-gynecologic-malignancies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.53470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,2]]}}}